-
Study aim
-
By understanding the hemodynamic effects of Propofol-Fentanyl and Propofol-Lidocaine in patients undergoing endoscopy, a combination can be used during endoscopy that makes patients less prone to hemodynamic changes.
-
Design
-
Clinical trial with 2 groups of Fentanyl and Lidocaine, with parallel groups, single-blind, randomized, phase 3 on 198 patients. R block statistical software is used for block randomization.
-
Settings and conduct
-
The present study will be performed in Afzalipour Hospital in Kerman. Hemodynamics (blood pressure, heart rate, arterial blood oxygen saturation and respiration rate) once before drug administration and once after drug injection before endoscopy and then every 5 minutes until completion of work through the patient monitoring system are checked and registered. The patient's tolerance should then be checked which is characterized by gagging or shaking hands.
After the endoscopy, we check which group of drugs the patients wake up earlier.
In order to blind one-way study, all data entry measures will be performed by a person unaware of the patient group.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria include patients undergoing upper endoscopy aged 20 to 40 years.Exclusion criteria included patient addiction, hypertension, hyperlipidemia, thyroid disease and any other comorbidities, also contraindications to Lidocaine use, including patients with G6PD, myasthenia gravis, methemoglobinemia, heart block, and Wolff-Parkinson-White syndrome, Adams-Stokes syndrome and low blood potassium levels.
-
Intervention groups
-
All patients were given 0.05 mg / kg Midazolam and 40 mg / min Propofol and randomly given 1 ug / kg Fentanyl to the first group and 1.5 mg / kg intravenous Lidocaine to the second group 90 seconds before each procedure.
-
Main outcome variables
-
Reduction of blood pressure fluctuations, heart rate, respiration rate, etc. during upper endoscopy